Market Overview:
The global pharmacokinetics services market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for pharmacokinetics services from small and medium enterprises (SMEs) and large enterprises, and rising prevalence of chronic diseases. The small molecules pharmacokinetics services segment is expected to grow at a CAGR of 8.0% from 2018 to 2030, while the large molecules (biopharmaceuticals) pharmacokinetics services segment is projected to grow at a CAGR of 7.3%. The SMEs segment is estimated to account for the majority share of the global pharmacokinetics services market in 2018, while the large enterprise segment is projected to register highest growth during the forecast period. Geographically, North America accounted for majority share of global Pharmacokinetic Services Market in 2017 followed by Europe and Asia Pacific region respectively .
Product Definition:
Pharmacokinetics Services is the study of how drugs move through the body and are metabolized. This information is used to develop dosage regimens that optimize drug effectiveness and minimize potential side effects. Pharmacokinetics Services are important because they help ensure that patients receive safe and effective treatment with minimal adverse effects.
Small Molecules Pharmacokinetics Services:
Small molecules pharmacokinetics (PK) is the branch of pharmacology that studies the fate of a drug after administration. It's an important aspect of pharmaceutical marketing as it helps in predicting how a particular drug will perform in vivo and help in developing effective dosage forms. PK involves various aspects such as absorption, distribution, metabolism by different organs and tissues, and excretion pathways for each route of administration.
Large Molecules (Biopharmaceuticals) Pharmacokinetics Services:
Large molecules (biopharmaceuticals) pharmacokinetics services and it's usage in the market? Large molecules (biopharmaceuticals) are complex organic compounds. They can be administered to humans or animals by various routes of administration such as oral, intravenous, intramuscular, intraperitoneal and subcutaneous. The route of administration depends on the type of drug being manufactured.
Application Insights:
The large enterprise segment dominated the global market in 2017. This can be attributed to factors such as size and complexity of pharmacokinetics studies required for drug development, high cost of pharmacokinetic studies and analysis, and presence of a dedicated team for these types of studies. The small & medium enterprise (SME) segment is expected to witness lucrative growth over the forecast period due to increasing demand from smaller companies or start-ups for developing drugs that are effective in humans. SMEs usually lack the internal expertise needed for designing complex clinical trials with multiple participants; however, they have sufficient financial resources and are ready to incur external costs associated with pharmacokinetics research.
Pharmaceutical companies conduct extensive preclinical testing before undertaking clinical trials involving human participants. Factors such as product portfolio evaluation, commercialization strategy evaluation & decisions on new product launch etc.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of key players, favorable government initiatives, and increasing R&D activities are some factors driving the regional market. Asia Pacific is expected to be the fastest-growing region during the forecast period due to rising healthcare expenditure and improving economic conditions in emerging countries such as China & India. Moreover, growing awareness regarding drug safety & efficacy along with an increase in spending on medicines by patients is also anticipated to drive growth over this period.
The European pharmacokinetic services industry is expected to grow at a significant rate over the forecast period owing to its well-developed healthcare infrastructure coupled with high patient awareness levels pertainingto medication efficacy & safety issues across Europe especially Germany UK France Italy Spain.
Growth Factors:
- Increasing demand for personalized medicine and companion diagnostics
- Rising prevalence of chronic diseases and growing geriatric population
- Growing number of clinical trials and drug development programs
- Technological advancements in pharmacokinetics services
- Expansion of the pharmaceuticals industry
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmacokinetics Services Market Research Report
By Type
Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
By Application
Small & Medium Enterprise, Large Enterprise
By Companies
Evotec AG (Germany), Pacific BioLabs (US), GVK Biosciences Private Limited (India), Shanghai Medicilon Inc. (China), Pharmaceutical Product Development, LLC (US), Charles River Laboratories International, Inc. (US), PAREXEL International Corporation (US), Eurofins Scientific, Inc. (Luxembourg), Frontage Labs (US), SGS SA (Switzerland), LGC Limited (UK), Creative Bioarray (US), Certara, L.P. (Germany)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
181
Number of Tables & Figures
127
Customization Available
Yes, the report can be customized as per your need.
Global Pharmacokinetics Services Market Report Segments:
The global Pharmacokinetics Services market is segmented on the basis of:
Types
Small Molecules Pharmacokinetics Services, Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Small & Medium Enterprise, Large Enterprise
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Evotec AG (Germany)
- Pacific BioLabs (US)
- GVK Biosciences Private Limited (India)
- Shanghai Medicilon Inc. (China)
- Pharmaceutical Product Development, LLC (US)
- Charles River Laboratories International, Inc. (US)
- PAREXEL International Corporation (US)
- Eurofins Scientific, Inc. (Luxembourg)
- Frontage Labs (US)
- SGS SA (Switzerland)
- LGC Limited (UK)
- Creative Bioarray (US)
- Certara, L.P. (Germany)
Highlights of The Pharmacokinetics Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Small Molecules Pharmacokinetics Services
- Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
- By Application:
- Small & Medium Enterprise
- Large Enterprise
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmacokinetics Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmacokinetics Services is a company that provides pharmacokinetic (PK) modeling and simulation services to the pharmaceutical industry. PK modeling is used to help identify how different drugs interact with one another in the body, and can also be used to predict how patients will respond to medications. Simulation is often used in conjunction with PK modeling, as it can help researchers determine which dosage of a drug would be most effective for a particular patient.
Some of the major companies in the pharmacokinetics services market are Evotec AG (Germany), Pacific BioLabs (US), GVK Biosciences Private Limited (India), Shanghai Medicilon Inc. (China), Pharmaceutical Product Development, LLC (US), Charles River Laboratories International, Inc. (US), PAREXEL International Corporation (US), Eurofins Scientific, Inc. (Luxembourg), Frontage Labs (US), SGS SA (Switzerland), LGC Limited (UK), Creative Bioarray (US), Certara, L.P. (Germany).
The pharmacokinetics services market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmacokinetics Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmacokinetics Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmacokinetics Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmacokinetics Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmacokinetics Services Market Size & Forecast, 2018-2028
4.5.1 Pharmacokinetics Services Market Size and Y-o-Y Growth
4.5.2 Pharmacokinetics Services Market Absolute $ Opportunity
Chapter 5 Global Pharmacokinetics Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharmacokinetics Services Market Size Forecast by Type
5.2.1 Small Molecules Pharmacokinetics Services
5.2.2 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharmacokinetics Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharmacokinetics Services Market Size Forecast by Applications
6.2.1 Small & Medium Enterprise
6.2.2 Large Enterprise
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmacokinetics Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmacokinetics Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharmacokinetics Services Analysis and Forecast
9.1 Introduction
9.2 North America Pharmacokinetics Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharmacokinetics Services Market Size Forecast by Type
9.6.1 Small Molecules Pharmacokinetics Services
9.6.2 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharmacokinetics Services Market Size Forecast by Applications
9.10.1 Small & Medium Enterprise
9.10.2 Large Enterprise
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharmacokinetics Services Analysis and Forecast
10.1 Introduction
10.2 Europe Pharmacokinetics Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharmacokinetics Services Market Size Forecast by Type
10.6.1 Small Molecules Pharmacokinetics Services
10.6.2 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharmacokinetics Services Market Size Forecast by Applications
10.10.1 Small & Medium Enterprise
10.10.2 Large Enterprise
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharmacokinetics Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharmacokinetics Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharmacokinetics Services Market Size Forecast by Type
11.6.1 Small Molecules Pharmacokinetics Services
11.6.2 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharmacokinetics Services Market Size Forecast by Applications
11.10.1 Small & Medium Enterprise
11.10.2 Large Enterprise
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharmacokinetics Services Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharmacokinetics Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharmacokinetics Services Market Size Forecast by Type
12.6.1 Small Molecules Pharmacokinetics Services
12.6.2 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharmacokinetics Services Market Size Forecast by Applications
12.10.1 Small & Medium Enterprise
12.10.2 Large Enterprise
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharmacokinetics Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharmacokinetics Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharmacokinetics Services Market Size Forecast by Type
13.6.1 Small Molecules Pharmacokinetics Services
13.6.2 Large Molecules (Biopharmaceuticals) Pharmacokinetics Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharmacokinetics Services Market Size Forecast by Applications
13.10.1 Small & Medium Enterprise
13.10.2 Large Enterprise
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmacokinetics Services Market: Competitive Dashboard
14.2 Global Pharmacokinetics Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Evotec AG (Germany)
14.3.2 Pacific BioLabs (US)
14.3.3 GVK Biosciences Private Limited (India)
14.3.4 Shanghai Medicilon Inc. (China)
14.3.5 Pharmaceutical Product Development, LLC (US)
14.3.6 Charles River Laboratories International, Inc. (US)
14.3.7 PAREXEL International Corporation (US)
14.3.8 Eurofins Scientific, Inc. (Luxembourg)
14.3.9 Frontage Labs (US)
14.3.10 SGS SA (Switzerland)
14.3.11 LGC Limited (UK)
14.3.12 Creative Bioarray (US)
14.3.13 Certara, L.P. (Germany)
